2023 - Research.com Medicine in United States Leader Award
2022 - Research.com Best Scientist Award
2018 - Fellow of the American Academy of Arts and Sciences
2009 - Fellow of the American Association for the Advancement of Science (AAAS)
2007 - Member of the National Academy of Sciences
2005 - Member of the National Academy of Medicine (NAM)
Member of the Association of American Physicians
Gerald I. Shulman focuses on Endocrinology, Internal medicine, Insulin resistance, Insulin and Type 2 diabetes. His Endocrinology study focuses mostly on Diabetes mellitus, Carbohydrate metabolism, Glycogen synthase, Glucose clamp technique and Skeletal muscle. Adipose tissue, Glucose uptake, Glucose transporter, Glycogen and Gluconeogenesis are the subjects of his Internal medicine studies.
His Insulin resistance research includes elements of Nonalcoholic fatty liver disease, Fatty liver, Steatosis and Type 2 Diabetes Mellitus. Insulin and Offspring are commonly linked in his work. His Type 2 diabetes research includes themes of Acetyl-CoA carboxylase and Mitochondrion.
His main research concerns Internal medicine, Endocrinology, Insulin resistance, Insulin and Type 2 diabetes. His Internal medicine study frequently draws parallels with other fields, such as Diabetes mellitus. His study in Insulin receptor, Adipose tissue, Glycogen, Glycogen synthase and Carbohydrate metabolism falls within the category of Endocrinology.
His biological study spans a wide range of topics, including Steatosis, Lipogenesis, Lipid metabolism, Diacylglycerol kinase and Nonalcoholic fatty liver disease. In his work, Glycogenolysis and Pyruvate carboxylase is strongly intertwined with Gluconeogenesis, which is a subfield of Insulin. His Mitochondrion research extends to the thematically linked field of Type 2 diabetes.
Gerald I. Shulman mainly focuses on Internal medicine, Endocrinology, Insulin resistance, Insulin and Type 2 diabetes. His Insulin resistance study incorporates themes from Nonalcoholic fatty liver disease, Fatty liver and Steatosis. The various areas that he examines in his Nonalcoholic fatty liver disease study include Protein kinase B and Glycogen synthase.
Many of his studies involve connections with topics such as Somatostatin and Insulin. While the research belongs to areas of Type 2 diabetes, he spends his time largely on the problem of Bioinformatics, intersecting his research to questions surrounding Obesity. His study looks at the relationship between Insulin receptor and topics such as Kinase, which overlap with Signal transduction.
Gerald I. Shulman mainly investigates Insulin resistance, Endocrinology, Internal medicine, Type 2 diabetes and Nonalcoholic fatty liver disease. Gerald I. Shulman is doing genetic studies as part of his Insulin and Diabetes mellitus and Insulin resistance investigations. His study involves Steatosis, Lipid metabolism, Gluconeogenesis, Lipolysis and Adipose tissue, a branch of Endocrinology.
Gerald I. Shulman interconnects Glucagon, Adipose triglyceride lipase and Fatty liver in the investigation of issues within Steatosis. Gerald I. Shulman has researched Type 2 diabetes in several fields, including Pathogenesis, Bioinformatics, Transcriptome, Transcription factor and White adipose tissue. His Nonalcoholic fatty liver disease study also includes
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cellular mechanisms of insulin resistance
Gerald I. Shulman.
Journal of Clinical Investigation (2000)
Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.
Kitt Falk Petersen;Sylvie Dufour;Douglas Befroy;Rina Garcia.
The New England Journal of Medicine (2004)
Mitochondrial dysfunction and type 2 diabetes.
Bradford B. Lowell;Gerald I. Shulman.
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Kitt Falk Petersen;Douglas Befroy;Sylvie Dufour;James Dziura.
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
Han Cho;James Mu;Jason K. Kim;Jason K. Kim;Joanne L. Thorvaldsen.
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Alejandro Henao-Mejía;Eran Elinav;Cheng Cheng Jin;Liming Hao.
Mechanisms for insulin resistance: common threads and missing links.
Varman T. Samuel;Gerald I. Shulman.
Disruption of IRS-2 causes type 2 diabetes in mice
Dominic J. Withers;Julio Sanchez Gutierrez;Heather Towery;Deborah J. Burks.
Mechanism of free fatty acid-induced insulin resistance in humans.
Michael Roden;Thomas B. Price;Gianluca Perseghin;Kitt Falk Petersen.
Journal of Clinical Investigation (1996)
Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle *
Chunli Yu;Yan Chen;Gary W. Cline;Dongyan Zhang.
Journal of Biological Chemistry (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: